Stryker is one of the world`s leading medical technology companies and is pushed with its clients to improve healthcare. The company offers innovative products and services over the years of orthopaedics, medicine and surgery, as well as neurotechnologies and spine that contribute to improving patient and hospital outcomes. For more information, see www.stryker.com. The tendering offer for Wright`s pending common shares has not yet begun. This announcement is neither a recommendation, an offer to purchase, nor an invitation to sell Common Shares of Wright or other securities. This communication can be considered as tender material for the CEM`s proposals (hereafter referred to). At the time of the offer, Stryker will submit a submission statement to the Securities and Exchange Commission (SEC) regarding the TO calendar and Wright will submit to the SEC an invitation/recommendation statement on Calendar 14D-9. Wright also intends to present a power of attorney to the SEC at an extraordinary general meeting of Wright, at which Wright shareholders will vote on certain decision proposals (the “EGM proposals”) regarding the transactions mentioned in this report and will send final power and a proxy card to each voting shareholder. SHAREHOLDERS ARE URGED TO READ THE TENDER OFFER STATEMENT (INCLUDING THE OFFER TO PURCHASE, A RELATED LETTER OF TRANSMITTAL AND OTHER OFFER DOCUMENTS), THE SOLICITATION/RECOMMENDATION STATEMENT ON SCHEDULE 14D-9 AND THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS TO ANY OF THE FOREGOING) WHEN SUCH DOCUMENTSOME BEC AVAILABLE, AS THEY WILL CONTAIN IMPORTANT INFORMATION THAT PERSONS SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING THEIR ORDINARY SHARES OR MAKING ANY VOTING DECISIONS. Shareholders can obtain these documents if they are submitted and available free of charge on the SEC`s website at www.sec.gov. Copies of the documents submitted by Stryker to the SEC will be available free of charge on Stryker`s website, www.stryker.com, or through Stryker`s Investor Relations Department under firstname.lastname@example.org.
Copies of Wright`s SEC filings will be available free of charge on Wright`s website www.wright.com or through Wright`s Investor Relations Division at email@example.com. In addition, Wright shareholders may receive free copies of the material offered by contacting the Information Officer for the offer mentioned in the Schedule TO offer statement. Bellingham Herald – Thanks to advances in medical technology, many surgical patients who would have spent a few nights in the hospital will now perform complex procedures in ambulances that they can install and relocate in less than a day. […] This press release contains information that contains or is based on forward-looking statements within the meaning of the Federal Securities and Exchange Act, which are subject to different risks and uncertainties that could cause our actual results to differ materially from those expressed or implied by such statements. These factors include failure to comply with any of the conditions for completing the Wright acquisition, including obtaining the necessary regulatory approvals (and the risk that such authorizations may lead to the imposition of conditions that could affect the expected profits of the transaction); delays in wright`s acquisition; liabilities, costs, costs or unforeseen expenses related to the acquisition of Wright; The impact of the proposed transaction on Wright (or its announcement) on the parties` relationships with employees, customers, other business partners or public authorities; weakening economic conditions that could have a negative impact on demand for our products; Price pressure in general, including cost control measures, which could have a negative impact on the price or demand of our products; changes in foreign exchange markets; Legislative and regulatory measures unforeseen problems related to clinical trials and which, by other means,